Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

793

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

September 30, 2005

Study Completion Date

October 31, 2007

Conditions
Lung DiseasesBronchopulmonary Dysplasia
Interventions
DRUG

iNO

Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants

OTHER

Placebo

Inhaled Nitrogen

Trial Locations (14)

15213

Magee-Women's Hospital, Pittsburgh

19107

Pennsylvania Hospital, Philadelphia

27599

University of North Carolina Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

29425

Medical University of South Carolina, Charleston

37232

Vanderbilt University Medical Center, Nashville

52242

University of Iowa Hospital & Clinics, Iowa City

73104

Children's Hospital of Oklahoma, Oklahoma City

84604

Utah Valley Regional Medical Center, Provo

85013

St. Joseph's Hospital, Phoenix

90033

Univeristy of Southern California/Good Samaritan Hospital, Los Angeles

92350

Loma Linda University Medical Center, Loma Linda

80218-1088

Children's Hospital, Denver

06030

University of Connecticut Health Center, Farmington

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Colorado, Denver

OTHER

NCT00006401 - Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants | Biotech Hunter | Biotech Hunter